Outward FDI from Israel's Largest Mnes Continues to Rise in 2011
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
HOUSTON REAL ESTATE MISSION to ISRAEL March 3-9, 2018
Program dated: May 24, 2017 HOUSTON REAL ESTATE MISSION TO ISRAEL March 3-9, 2018 D a y O n e : Saturday, March 3, 2018 DEPARTURE . Depart the U.S.A. Overnight: Flight D a y T w o : Sunday, March 4, 2018 TLV 24/7 . 12:00 p.m. Meet your tour educator in the hotel lobby. Enjoy lunch at Blue Sky, with it’s a wide selection of fish, vegetables, olive oil and artisan cheese, accompanied with local wines and overlooking the stunning views of the Mediterranean Sea. A Look into Our Journey: Tour orientation with the Mission Chair and the tour educator. The Booming Tel Aviv Real Estate Market: Take a tour of various locations around Tel Aviv with Ilan Pivko, a leading Israeli Architect and entrepreneur. Return to the hotel. Cocktails overlooking the Mediterranean Sea. Combining Business Abroad and Real Estate in Israel: Dinner at 2C with Danna Azrieli, the Acting Chairman of The Azrieli Group, at the Azrieli Towers. Overnight: Tel Aviv D a y T h r e e : Monday, March 5, 2018 FROM RED ROOFTOPS TO HIGH-RISERS . The Laws of Urban Development in Israel: Private breakfast at the hotel with Dr. Efrat Tolkowsky, CEO of the Gazit-Globe Real Estate Institute at IDC. Stroll down Rothschild Boulevard to view examples of the intriguing Bauhaus-style architecture from the 1930s; the local proliferation of the style won Tel Aviv recognition as a UNESCO World Heritage site and the nickname of ‘the White City'. Explore the commercial and residential developments with Dr. Micha Gross, the head of the Tel Aviv Bauhaus Center. -
Bigitech Fact Sheet 2017.12
BlueStar Israel Global Technology IndexTM TM Q417 BIGITech Fact Sheet INDEX OVERVIEW The BlueStar Israel Global Technology IndexTM provides a benchmark for investors to track Israeli and Israel-linked technology companies trading worldwide. The index is constructed using BlueStar Indexes’ unique methodology and proprietary database of Israeli and Israel- linked companies. BIGITechTM is a modified market capitalization weighted index, capping the top-weighted constituents at 10%. It includes the largest and most liquid technology companies, as well as mid and small cap companies that display sufficient liquidity for global investors. The methodology allows for the inclusion of Israeli companies listed on the Tel Aviv Stock Exchange and other major exchanges such as the London Stock Exchange, New York Stock Exchange, and NASDAQ. Furthermore the methodology provides for the inclusion of companies that develop, manufacture, and/or deliver innovative technologies in a wide range of tech sectors, including Bio- Tech, Agriculture-Tech, Defense-Tech, Clean-Tech as well as Info-tech. Top Ten Index Constituents GICS Industry Exposure Company Index Weight (%) Industry Weight (%) Nice Ltd 7.63 Software 27.78 Amdocs Ltd 7.44 Semiconductors & Semiconductor 14.49 Check Point Software Tech 7.11 IT Services 10.15 Tower Semiconductor Ltd 4.66 Biotechnology 7.52 Elbit Systems Ltd 4.41 Internet Software & Services 5.47 Mellanox Technologies Ltd 4.26 Aerospace & Defense 5.45 Verint Systems Inc 3.89 Communications Equipment 5.24 Ormat Technologies Inc 3.52 Health Care Equipment & Suppli 4.86 Wix.Com Ltd 3.37 Independent Power and Renewabl 4.36 Orbotech Ltd 3.26 Electronic Equipment, Instrume 3.96 Total 49.52 Technology Hardware, Storage & 1.70 Diversified Financial Services 1.68 Pharmaceuticals 1.49 Hotels, Restaurants & Leisure 1.43 Machinery 1.38 BIGITech™ Internal Index Data Commercial Services & Supplies 0.69 Other 12.35 Index Statistics No. -
Frutarom Industries Ltd. Directors' Report of the Company's State of Affairs for the Period Ended June 30, 2018 A. Review Of
FRUTAROM INDUSTRIES LTD. DIRECTORS' REPORT OF THE COMPANY'S STATE OF AFFAIRS FOR THE PERIOD ENDED JUNE 30, 2018 BOARD OF DIRECTORS' DISCUSSIONS ON THE COMPANY'S STATE OF BUSINESS A. REVIEW OF ACTIVITY Frutarom Industries Ltd. (the "Company”) is a global company established in Israel in 1933. Frutarom became a public company in 1996 upon registration of its shares for trade on the Tel Aviv Stock Exchange. In February 2005, the Company’s Global Depository Receipts were also listed on the London Stock Exchange Official List. The Company, itself and through its subsidiaries ("Frutarom" or the "Group") develops, produces and markets flavors and fine ingredients used in the manufacturing of food, beverages, flavors and fragrances, pharma/nutraceuticals, cosmetics and personal care products. As of the date of the publication of the report Frutarom operated 73 production sites, 92 research and development laboratories, and 110 sales offices in Europe, North America, Latin America, Israel, Asia, Africa and New Zealand, and it marketed and sold over 70,000 products to more than 30,000 customers in more than 150 countries and employs approx. 5,600 people throughout the world. On May 7, 2018, Frutarom signed a merger agreement (the "Merger Agreement") with International Flavors & Fragrances Inc. (the "Purchasing Company") an international public company, whose securities are listed for trading on the New York Stok Exchange (under the symbol IFF) and on the Euronext Paris Stock Exchange (under the symbol IFF) and Icon Newco Ltd, a private company -
Strauss Group Sustainability Report 2020
Strauss Group Sustainability Report 2020 GRI Content Index 1 STRAUSS GROUP 2020 SUSTAINABILITY REPORT - GRI CONTENT INDEX This is Strauss Group’s 13th sustainability report. It describes the impact of the Group’s business, social and environmental activities on its stakeholders in 2020. This report was prepared in accordance with standards of the Global Reporting Initiative (GRI): Core Option. Furthermore, the report represents the Group’s annual report to the Global Compact project of the United Nations, which it has been a member of since 2008. The information in the report refers to the 2020 calendar year. Our previous full sustainability report was published in 2020 and referred to 2019. We intend to continue to publish our sustainability report on an annual basis. In this report, we kept to the same essential framework from 2014. Based on strategic work that was carried out in 2019 and on internal verification, we found that this framework is still relevant today. The parameters of this report are unchanged – the report deals with all the companies in Strauss Group that are under our operational control, including joint ventures that are reported as full entities. No substantial retroactive amendments were made to data that was presented in previous reports. Minor adjustments that were made are indicated alongside the data as they are shown. This summary, as well as the 2020 Sustainability Report are not part of Strauss Group’s financial, immediate or periodic statements. In the event of a discrepancy between what is stated in this report and the aforementioned reports, the wording of the financial statements is the binding one. -
Retirement Strategy Fund 2060 Description Plan 3S DCP & JRA
Retirement Strategy Fund 2060 June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA ACTIVIA PROPERTIES INC REIT 0.0137% 0.0137% AEON REIT INVESTMENT CORP REIT 0.0195% 0.0195% ALEXANDER + BALDWIN INC REIT 0.0118% 0.0118% ALEXANDRIA REAL ESTATE EQUIT REIT USD.01 0.0585% 0.0585% ALLIANCEBERNSTEIN GOVT STIF SSC FUND 64BA AGIS 587 0.0329% 0.0329% ALLIED PROPERTIES REAL ESTAT REIT 0.0219% 0.0219% AMERICAN CAMPUS COMMUNITIES REIT USD.01 0.0277% 0.0277% AMERICAN HOMES 4 RENT A REIT USD.01 0.0396% 0.0396% AMERICOLD REALTY TRUST REIT USD.01 0.0427% 0.0427% ARMADA HOFFLER PROPERTIES IN REIT USD.01 0.0124% 0.0124% AROUNDTOWN SA COMMON STOCK EUR.01 0.0248% 0.0248% ASSURA PLC REIT GBP.1 0.0319% 0.0319% AUSTRALIAN DOLLAR 0.0061% 0.0061% AZRIELI GROUP LTD COMMON STOCK ILS.1 0.0101% 0.0101% BLUEROCK RESIDENTIAL GROWTH REIT USD.01 0.0102% 0.0102% BOSTON PROPERTIES INC REIT USD.01 0.0580% 0.0580% BRAZILIAN REAL 0.0000% 0.0000% BRIXMOR PROPERTY GROUP INC REIT USD.01 0.0418% 0.0418% CA IMMOBILIEN ANLAGEN AG COMMON STOCK 0.0191% 0.0191% CAMDEN PROPERTY TRUST REIT USD.01 0.0394% 0.0394% CANADIAN DOLLAR 0.0005% 0.0005% CAPITALAND COMMERCIAL TRUST REIT 0.0228% 0.0228% CIFI HOLDINGS GROUP CO LTD COMMON STOCK HKD.1 0.0105% 0.0105% CITY DEVELOPMENTS LTD COMMON STOCK 0.0129% 0.0129% CK ASSET HOLDINGS LTD COMMON STOCK HKD1.0 0.0378% 0.0378% COMFORIA RESIDENTIAL REIT IN REIT 0.0328% 0.0328% COUSINS PROPERTIES INC REIT USD1.0 0.0403% 0.0403% CUBESMART REIT USD.01 0.0359% 0.0359% DAIWA OFFICE INVESTMENT -
Bluestar Israel Quarterly Update Q3 2013 Final.Pptx
BlueStar Israel Equity Update Third Quarter 2013 Q2 2013 in Review & Second Half 2013 Outlook What’s Inside Ø Global developed market equities pulled back slightly in Q2 2013 while U.S. stocks, as measured by the S&P 500 index, bucked the trend and posted a rise of 2.91%. Ø The BlueStar Israel Global Index was down by 95 bps in Q2 2013 while the MSCI Israel and TA-100 indexes were down 4.16% and 2.76%, respectively. 1. The BlueStar Ø Israeli consumer stocks, which are correlated with both domestic consumption as well as consumer spending in Israel’s export markets, lead Israeli Global Equities in Q2, while the Israel Global financial and energy stocks, which lead the Israeli Global Equity market’s rebound from the Index in Q1 2012 lows, consolidated. 2013 Ø The Israeli government decided on a 2013 and 2014 budget that will result in tax increases and spending cuts and the Shekel’s sharp appreciation versus the dollar and euro eased a bit. 2-5. About the Ø Mellanox Technologies announced it will delist its shares from the Tel Aviv Stock Exchange and the TASE’s bid to be included in MSCI’s European regional indexes was declined. Both BlueStar Israel events sparked concern about the future of the local exchange. Also, Israeli corporate Global Index pyramids come under attack by The Committee on Increasing Competitiveness in the Economy and the Business Concentration Law. (including Risk/ Ø The Energy sector is asserting itself as a major player in the Israeli economy, natural gas Return Data) reserve estimates and oil estimates are rising, and the government has decided upon an export strategy, clearing up uncertainty and removing some of the risk factors associated with investing in that sector. -
Ormat Technologies Inc
ORMAT TECHNOLOGIES INC MEETING DATE Wed, 06 Nov 2019 13:00 TYPE EGM ISSUE DATE Fri, 25 Oct 2019 MEETING LOCATION 6140 Plumas Street, Reno, NV 89519 CURRENT INDICES PIRC Global SECTOR Electric services COMPANY OVERVIEW Ormat Technologies is a provider of renewable power and energy technology. The Company is based in Reno, Nevada, and has over 150 power plants. MEETING SPECIFIC INFORMATION Ordinary resolutions are approved by simple majority of the votes cast. PROPOSALS ADVICE 1 Board Proposal to Declassify the Board For It is considered that staggered elections do not pursue shareholders’ best interest, as they entrench the board against hostile takeovers. In this sense, the Board’s proposal is welcomed as it will introduce annual election for all directors of the board, which is considered to be best practice. 2 Adjourn Meeting Oppose The Board requests authority to adjourn the special meeting until a later date or dates, if necessary, in order to permit further solicitation of proxies if there are not sufficient votes at the time of the special meeting to approve the merger. An oppose vote is recommended to any adjournment or postponement of meetings if a sufficient number of votes are present to constitute a quorum. It is considered that where a quorum is present, the vote outcome should be considered representative of shareholder opinion. ORMAT TECHNOLOGIES INC 06 Nov 2019 EGM 1 of 5 BOARD AND COMMITTEE COMPOSITION (post-Meeting) INDEPENDENT BY DIRECTOR GENDER PIRC COMPANY BOARD AC RC NC SC TENURE Dan Falk M No Yes NED C M M - 14 Todd C. -
Israel: Anti- Fragile
I N T E R N AT I O N A L > I S R A E L Israel: Anti- fragile Battered by regional turbulence, Israel’s tech-infused economy has made virtue of handling challenge and adversity. Its legal profession is no exception 29 October 2019 09:30am Dominic Carman Middle East and Africa Corporate Legal tech Thriving in the face of adversity as politics and security play an integral part in everyday life is a default position for Israel. The data backs this up: recent OECD reports describe Israel as stable with strong economic growth: annual GDP has consistently risen by three to four percent over recent years to reach nearly $400bn in 2019. This, despite a protracted leadership battle taking place with two general elections in six months bringing the nation no closer to a conclusive result. Michael Barnea, managing partner of Barnea, Jaffa, Lande & Co, develops the point: ‘The environment is surprisingly robust considering the political instability that we’ve experienced for a considerable time. Investment, both from overseas into Israel and in the local market, is extremely strong and gives every appearance of being confident in the future.’ Despite international law firms being allowed to operate in Israel, they have invariably chosen not to. The legal market is therefore monopolised by domestic players, many of which have grown significantly and the main contributory factor has been a glut of mergers. According to David Tadmor, co-chairman and managing partner of Tadmor Levy, today the largest firm has close to 400 fee- earners, whereas in 2000 it was around 65 lawyers. -
Central Intelligence Agency (CIA) Freedom of Information Act (FOIA) Case Log October 2000 - April 2002
Description of document: Central Intelligence Agency (CIA) Freedom of Information Act (FOIA) Case Log October 2000 - April 2002 Requested date: 2002 Release date: 2003 Posted date: 08-February-2021 Source of document: Information and Privacy Coordinator Central Intelligence Agency Washington, DC 20505 Fax: 703-613-3007 Filing a FOIA Records Request Online The governmentattic.org web site (“the site”) is a First Amendment free speech web site and is noncommercial and free to the public. The site and materials made available on the site, such as this file, are for reference only. The governmentattic.org web site and its principals have made every effort to make this information as complete and as accurate as possible, however, there may be mistakes and omissions, both typographical and in content. The governmentattic.org web site and its principals shall have neither liability nor responsibility to any person or entity with respect to any loss or damage caused, or alleged to have been caused, directly or indirectly, by the information provided on the governmentattic.org web site or in this file. The public records published on the site were obtained from government agencies using proper legal channels. Each document is identified as to the source. Any concerns about the contents of the site should be directed to the agency originating the document in question. GovernmentAttic.org is not responsible for the contents of documents published on the website. 1 O ct 2000_30 April 2002 Creation Date Requester Last Name Case Subject 36802.28679 STRANEY TECHNOLOGICAL GROWTH OF INDIA; HONG KONG; CHINA AND WTO 36802.2992 CRAWFORD EIGHT DIFFERENT REQUESTS FOR REPORTS REGARDING CIA EMPLOYEES OR AGENTS 36802.43927 MONTAN EDWARD GRADY PARTIN 36802.44378 TAVAKOLI-NOURI STEPHEN FLACK GUNTHER 36810.54721 BISHOP SCIENCE OF IDENTITY FOUNDATION 36810.55028 KHEMANEY TI LEAF PRODUCTIONS, LTD. -
Elbit Medical Technologies Initiation of Coverage
Elbit Medical Technologies Initiation of coverage Two promising private assets Pharma & biotech 28 June 2018 Elbit Medical Technologies is an Israel-based healthcare investment company traded on the TASE. It is invested in two private companies: Price* NIS1.12 InSightec is a commercial-stage medical device company marketing a non- Market cap NIS259m invasive thermal tissue ablation therapy in three indications and Gamida *Priced as at 26 June 2018 Cell is a cell and immune therapy company developing a universal bone NIS3.64/US$ marrow transplant (BMT) product for haematological malignancies. Net debt ($m) at 31 December 2017 42.4 Although their recent offerings of NIS182m of convertible notes lengthen Shares in issue 231.4m the cash runway it raises the prospect of dilution in 2022. In addition, the Free float 10.8% parent company Elbit Imaging (~89% owned) has its own challenges. We value Elbit Medical at NIS407m or NIS1.76 per share. Code EMTC Primary exchange TASE Revenue PBT* EPS* DPS P/E Yield Secondary exchange N/A Year end ($m) ($m) ($) ($) (x) (%) 12/15 1.8 (1.1) 0.0 0.0 N/A N/A Share price performance 12/16 0.0 (3.7) 0.0 0.0 N/A N/A 12/17 0.0 (5.2) 0.0 0.0 N/A N/A Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. InSightec: A non-invasive operating room Elbit Medical currently holds a ~22% (~19% fully diluted) stake in InSightec, a commercial-stage medical device company. -
NASDAQ Stock Market
Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85 -
Proxy Statement for Annual General Meeting of Shareholders 2019
GILAT SATELLITE NETWORKS LTD. Gilat House 21 Yegia Kapayim St. Kiryat Arye Petah Tikva 4913020, Israel ____________________ NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To be held on June 20, 2019 To our Shareholders: We cordially invite you to the Annual General Meeting of Shareholders of Gilat Satellite Networks Ltd. (the “Company”) to be held at the offices of the Company at 21 Yegia Kapayim Street, Kiryat Arye, Petah Tikva 4913020, Israel, on June 20, 2019 at 2 p.m. Israel time for the following purposes (the “Meeting”): 1. To set the number of directors serving on the Company Board at eight; 2. To re-elect six members of the Board of Directors until our next annual general meeting of shareholders and until their successors have been duly elected and qualified; 3. To approve an annual cash bonus plan for the Chief Executive Officer of the Company; 4. To approve a grant of options to the Chief Executive Officer of the Company; 5. To approve an annual cash bonus plan for the Chairman of the Company’s Board of Directors; 6. To amend our compensation policy for the Company’s directors and officers; and 7. To ratify and approve the reappointment and compensation of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the fiscal year ending December 31, 2019, and for such additional period until the next annual general meeting of shareholders. In addition, our consolidated financial statements for the year ended December 31, 2018 will be received and considered at the Meeting.